Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neuropathies associated with paraproteinemia.

Literature DB >> 9603799

Neuropathies associated with paraproteinemia.

A H Ropper¹, K C Gorson.

Abstract

Entities: Disease

Mesh：

Substances：
Antigens
Glycoconjugates

Year: 1998 PMID： 9603799 DOI： 10.1056/NEJM199805283382207

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

26 in total

Review 1. Management of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors: Richard A C Hughes
Journal: Drugs Date: 2003 Impact factor: 9.546

2. Pathogenesis and treatment of immune-mediated neuropathies.

Authors: Helmar C Lehmann; Gerd Meyer Zu Horste; Bernd C Kieseier; Hans-Peter Hartung
Journal: Ther Adv Neurol Disord Date: 2009-07 Impact factor: 6.570

3. Subclinical peripheral neuropathy in patients with multiple myeloma before chemotherapy is correlated with decreased fingertip innervation density.

Authors: Alyssa K Kosturakis; Zijing He; Yan Li; Jessica A Boyette-Davis; Nina Shah; Sheeba K Thomas; Haijun Zhang; Elisabeth G Vichaya; Xin Shelley Wang; Gwen Wendelschafer-Crabb; William R Kennedy; Donald A Simone; Charles S Cleeland; Patrick M Dougherty
Journal: J Clin Oncol Date: 2014-08-25 Impact factor: 44.544

4. Waldenstrom-associated anti-MAG paraprotein polyneuropathy with neurogenic tremor.

Authors: Carlo Canepa
Journal: BMJ Case Rep Date: 2019-03-31

5. Monoclonal gammopathy of undetermined significance: significant beyond hematology.

Authors: Steven Vanderschueren; Marieke Mylle; Daan Dierickx; Michel Delforge; Peter Verhamme; Kathelijne Peerlinck; Wouter Meersseman; Daniël C Knockaert
Journal: Mayo Clin Proc Date: 2009-09 Impact factor: 7.616

6. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy.

Authors: Jean-Marc Léger; Karine Viala; Guillaume Nicolas; Alain Créange; Jean-Michel Vallat; Jean Pouget; Pierre Clavelou; Christophe Vial; Andreas Steck; Lucile Musset; Benoit Marin
Journal: Neurology Date: 2013-05-10 Impact factor: 9.910

7. Incidence of chemotherapy-induced peripheral neuropathy within 12 weeks of starting neurotoxic chemotherapy for multiple myeloma or lymphoma: a prospective, single-center, observational study.

Authors: Veronica B Ajewole; James E Cox; Joshua T Swan; Soumya G Chikermane; Beverly Lamoth; Tomona Iso; Laura O Okolo; Christen L Ford; Amy M Schneider; Eleanor C Hobaugh; Kelty R Baker
Journal: Support Care Cancer Date: 2019-07-29 Impact factor: 3.603